China SXT Pharmaceuticals SXTC
NASDAQ SXTC
$2.81 +0.29 (+11.51%)
At close: Sep 29, 2026 · 4:00 PM EDT

China SXT Pharmaceuticals (SXTC) Net Cash Flow (2017 - 2019)

Updated

China SXT Pharmaceuticals' Net Cash Flow was $9.17 million in FY2026 (year ended Mar 31, 2026), up 49.8% from $6.12 million in FY2025.

Analysis

China SXT Pharmaceuticals (SXTC) Net Cash Flow (2017 - 2019) Analysis & Trends

From FY2017 onward, China SXT Pharmaceuticals has reported Net Cash Flow for 10 fiscal years.

  • Net Cash Flow shows a five-year compound annual growth rate of 11.6% (FY2021 to FY2026).
  • The FY2026 figure marks the highest annual Net Cash Flow in data going back to FY2017.
  • Per Business Quant data, Net Cash Flow in earlier fiscal years was $6.12 million in FY2025, -$4.53 million in FY2024, $2.85 million in FY2023 (+56.8%) and $1.82 million in FY2022 (-65.6%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -1.27 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -2.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 1.53 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 757.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 1.62 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -4.43 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -722.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 652.90 Mn
10 China SXT Pharmaceuticals 33,069.96 -85.92 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 7.19 Mn
Dec 31, 2018 555,220.00
Dec 31, 2017 56,174.00
API Access

China SXT Pharmaceuticals Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=SXTC&period=max&api_key=YOUR_API_KEY